CASSANDRA SHORE: Open Payments
NPI 1982958682 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,091 in 61 payments from 13 companies in 2025. Trend: 2023 $1,656 · 2024 $1,776 · 2025 $1,091
Food & beverage: $1,091
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $232 |
| GENZYME CORPORATION | 5 | $196 |
| Arcutis Biotherapeutics, Inc. | 9 | $175 |
| Regeneron Healthcare Solutions, Inc. | 3 | $111 |
| Amgen Inc. | 5 | $95 |
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| LEO Pharma Inc. | 3 | $52 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $49 |
| MERZ NORTH AMERICA, INC. | 1 | $22 |
| Organon LLC | 3 | $21 |
Products named: DUPIXENT, Zoryve, SKYRIZI, OTEZLA, BOTOX, COSENTYX, Rhapsido, ILUMYA.
Industry payments across AZ — which companies pay providers there.
